barium titanate(iv) has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, R; Guduru, R; Hadjikhani, A; Horstmyer, J; Khizroev, S; Liang, P; Nagesetti, A; Salgueiro, L; Schally, A; Stewart, TS; Stimphil, E | 1 |
| Almici, E; Battaglini, M; Cappello, V; Cicchi, R; Ciofani, G; de Vito, G; Marchetti, M; Marino, A; Migliorin, S; Pavone, FS; Tapeinos, C | 1 |
2 other study(ies) available for barium titanate(iv) and Glioblastoma
| Article | Year |
|---|---|
Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
Topics: Antineoplastic Agents; Barium Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cobalt; Drug Carriers; Drug Liberation; Endothelial Cells; Ferric Compounds; Glioblastoma; Growth Hormone; Hormone Antagonists; Humans; Magnetic Fields; Magnetite Nanoparticles; Microvessels; Nanospheres; Particle Size; Peptides; Titanium | 2018 |
Piezoelectric barium titanate nanostimulators for the treatment of glioblastoma multiforme.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Barium Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Nanoparticles; Nanotechnology; Temozolomide; Titanium; Tumor Cells, Cultured | 2019 |